OmniAb
OABIMarket price data through October 30, 2026.
Performance
Nov 2021 – Oct 2026
Track record
How this pick has done since Benson first called it.
- Benson Return
- 0%
- How much this stock is up since Benson first picked it — measured from the price at the time of that first pick, not from today.
- First pick price
- ~$5
- Roughly what one share cost when Benson first picked this stock. This is the starting line for the Benson Return.
- Tracking since
- November 2026
- The month this stock first became a Benson pick.
- Tracking duration
- 0 months
- How long Benson has been tracking this pick.
About OmniAb
OmniAb helps drug makers find new antibody medicines. It is a bit like a toolbox rental shop for biotech: partners use its technology to search for drug candidates, and OmniAb earns fees up front, plus milestone payments and royalties if their drugs succeed. It works with 111 partners on 433 active programs.
The case for and against
Both sides of the story, in plain English.
- Revenue Is Surging
Revenue for the first nine months of 2026 was 31.8 million dollars, up from 10.3 million a year ago. In the latest quarter it grew 82 percent to 4.0 million dollars. Management just raised its full year outlook to between 35 and 39 million dollars.
- Big Partner Pipeline
OmniAb has 111 partners and 433 active programs, and 34 of them are already in clinical trials or on the market. A new Eli Lilly deal could pay up to 370 million dollars in milestones plus royalties, so each success adds income without much extra cost.
- Still Losing Money
OmniAb lost 29.3 million dollars in the first nine months of 2026, and its net margin is about negative 108 percent. It had 64.2 million dollars in cash at the end of September and expects to end the year near 55 million dollars while spending 50 to 54 million dollars a year in cash.
- Lumpy Revenue
Much of the growth came from milestone payments, which arrive only when partners hit goals. That makes results uneven from one quarter to the next. Last year's full year revenue fell about 29 percent, so the jump this year is not guaranteed to repeat.
Other companies we track
How to read this page
This automated research summary uses Financial Modeling Prep market data through 2026-10-30. Model signals, scores, and risk labels can change and may be incomplete or wrong.
Want Benson to watch OABI for you?
Get the app to follow every Benson pick live — and let Benson do the research for you.